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BETWEEN-CENTER AND BETWEEN-
COUNTRY DIFFERENCES IN OUTCOME
AFTER ANEURYSMAL SUBARACHNOID
HEMORRHAGE IN THE SUBARACHNOID
HEMORRHAGE INTERNATIONALTRIALISTS
(SAHIT) REPOSITORY
S. Dijkland1, B. Jaja2, M. van der Jagt3, B. Roozenbeek4,
E. Steyerberg1,5, D. Dippel4, R.L. Macdonald6, H. Lingsma1; on
behalf of the SAHIT collaborators
1Erasmus University Medical Center, Public Health, Rotterdam, The
Netherlands; 2Li Ka Shing Knowledge Institute- St. Michael’s Hospital-
University of Toronto, Neuroscience Research Program, Toronto,
Canada; 3Erasmus University Medical Center, Intensive Care, Rotterdam,
The Netherlands; 4Erasmus University Medical Center, Neurology,
Rotterdam, The Netherlands; 5Leiden University Medical Center,
Biomedical Data Sciences, Leiden, The Netherlands; 6Keenan Research
Center- Li Ka Shing Knowledge Institute- St. Michael’s Hospital-
University of Toronto, Surgery, Toronto, Canada
Background and Aims: Differences in outcome among different set-
tings are common in many diseases and may reflect differences in quality
of care. We aimed to quantify between-center and between-country
differences in outcome after aneurysmal subarachnoid hemor-
rhage (aSAH).
Method: We analyzed data from 5530 aSAH patients from three ran-
domized clinical trials including 170 centers and 22 countries. We used
random-effects logistic regression adjusted for patient characteristics to
estimate between-center and between-country differences in unfavorable
outcome, defined as Glasgow Outcome Scale 1–3 (severe disability, veg-
etative state or death) or modified Rankin Scale 4–6 (moderately severe
disability, severe disability or death) at three months. Between-center and
between-country differences were quantified with the median odds ratio
(MOR), which is based on the variance of the random effects and can be
interpreted as the odds ratio for unfavorable outcome between two
randomly selected centers or countries. We analyzed the total database
and performed subgroup analysis stratified for continent (Europe, North
America and Oceania).
Results: The proportion of patients with unfavorable outcome was 27%.
We found substantial between-center differences (MOR¼ 1.26), which
were not explained by patient characteristics (adjusted MOR¼ 1.30).
Between-country differences were also found (adjusted MOR¼ 1.41).
Between-center differences were absent in Oceania and North
America (adjusted MOR¼ 1.00), but were present in Europe (adjust-
ed MOR¼ 1.51).
Conclusion: Outcome after aSAH differs between centers and coun-
tries, especially in Europe. Since these differences could not be explained
by patient characteristics, future research should focus on explanations
regarding differential treatment policies and quality of care.
Trial registration number: N/A
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SECONDARY TRANSFER OF STROKE
PATIENTS FOR THROMBECTOMY BYAIR
AMBULANCE IN ENGLAND: A COST-
EFFECTIVESS ANALYSIS
D. Flynn1, D. Coughlan1, P. McMeekin2, G.A. Ford3, D. Craig1,
S. Rice1, D. Burgess4, J. Balami5, A. Mawson6, H. Lumley3
and P. White3
1Newcastle University, Institute of Health and Society, Newcastle upon
Tyne, United Kingdom; 2Northumbria University, School of Health-
Community and Education Studies, Newcastle upon Tyne, United
Kingdom; 3Newcastle University, Institute of Neuroscience Stroke
Research Group, Newcastle upon Tyne, United Kingdom; 4Clinical
Research Network North East and North Cumbria, North East and
North Cumbria Stroke Patient & Carer Panel, Newcastle upon Tyne,
United Kingdom; 5University of Oxford, Centre for Evidence Based
Medicine, Oxford, United Kingdom; 6Great North Air Ambulance,
Northumberland Wing- The Imperial Centre, Darlington,
United Kingdom
Background and Aims: Helicopter Emergency Medical Services
(HEMS) for secondary transfer of stroke patients eligible for thrombec-
tomy could have a significant impact on outcomes for patients residing in
areas remote from a thrombectomy centre (TC). Remote units cannot
sustain a 24/7 thrombectomy service locally and transfer to a TC is
necessary. There are few data on cost-effectiveness of secondary transfer
via HEMS to inform commissioning decisions. We are evaluating the cost-
effectiveness of HEMS versus ground-based ambulance (GBA) for stroke
thrombectomy in England.
Method: Using Geographic Information System data, we identified
unavoidably remote hospitals serving a population of 800,000 (where
initiating a local sustainable 24/7 thrombectomy service is not feasible)
and >1 hour by GBA from the nearest designated TC. We previously
estimated the proportion of CT/CTA-confirmed stroke patients admitted
with NIHSS6 within 4.5 hours. Probability of receiving thrombectomy
via HEMS or GBA was derived from average journey times. Quality
Adjusted Life Years will be calculated for secondary transfer by HEMS
and GBA to the most proximal TC to derive an incremental cost-effec-
tiveness ratio.
Results: Annual stroke incidence of 3,860 at unavoidably remote hospi-
tals (75km transfer distance), of which 508 patients would be trans-
ferred by HEMS. Ongoing survey of HEMS to establish operational
parameters and costs to inform cost effectiveness model is ongoing
and will be presented with the health economic data.
Conclusion: HEMS is an option for secondary transfer of patients eligi-
ble for thrombectomy from unavoidably “small” and remote hospitals.
Estimates of HEMS cost-effectiveness will be presented to inform the
optimal organisation of thrombectomy service delivery.
Trial registration number: N/A
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VIDEO SUPPORT IN THE PREHOSPITAL
STROKE CHAIN
H. Maurin S€oderholm1, S. Candefjord2,3, M. Andersson
Hagiwara4, J.E. Karlsson5, L. Rosengren6 and B.A. Sj€oqvist2,3
1University of Bora˚s, Swedish School of Library and Information Science-
Prehospen Centre for Prehospital Research, Boras, Sweden; 2Chalmers
University of Technology, Department of Electrical Engineering,
Gothenburg, Sweden; 3Sahlgrenska University Hospital, MedTech West,
Gothenburg, Sweden; 4University of Bora˚s, Prehospen Centre for
Prehospital Research, Boras, Sweden; 5Sahlgrenska University Hospital,
Department of Neurology, Gothenburg, Sweden; 6the Sahlgrenska
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